Fingerprints' touch sensor FPC1268 featured in Huawei's new

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
272
Fingerprints' touch sensor FPC1268 featured in Huawei's new P10 series

Press release February 27, 2017

Fingerprints' touch sensor FPC1268 featured in Huawei's new P10 series

MOBILE WORLD CONGRESS 2017, BARCELONA. World-leading biometrics company Fingerprint Cards' (Fingerprints) touch sensor FPC1268 is featured in Huawei's new P10 series. Huawei's P10 series was launched yesterday in conjunction with Mobile World Congress in Barcelona. The P10 series includes smartphone models P10 and P10 Plus. "I'm proud to see that yet again, our industry-leading technology has been chosen by Huawei and that we continue our strong partnership with one of the industry's largest players. Innovation is key for us and we continue to develop holistic and industry-leading solutions in close collaboration with our customers and partners", says Christian Fredrikson, CEO of Fingerprint Cards.

As previously announced and demonstrated by Fingerprint Cards in February 2016, the FPC1268 is Fingerprint Cards' first solution optimized for thick materials like cover glass. This enables device manufacturers to integrate fingerprint sensors in new design languages, for example completely invisible under the cover glass or used as a home button covered by glass. In November 2016, Huawei launched the Mate 9 Porsche Design smartphone featuring FPC1268, which was the first commercial launch of the FPC1268 sensor.

"We're only in the beginning of the biometric era. The launch of the FPC1268 was an important milestone for us, but also an acknowledgement of our R&D team's strong technology know-how and drive and how our technology extends the barriers of what fingerprint sensors can enable", concludes Christian Fredrikson, CEO of Fingerprint Cards.

Already received as well as expected Fingerprint Cards revenues in 2017 that relate to the sales of FPC1268 for this smartphone model are included in Fingerprint Cards' communicated revenue guidance of 7500 - 9500 MSEK for 2017.

For further information, please contact Investor Relations, Fingerprint Cards AB (publ) Tel: +46(0)10-172 00 10 E-mail: investrel@fingerprints.com Press office, Fingerprint Cards AB (publ) Tel: +46(0)10-172 00 20 E-mail: press@fingerprints.com    

About Fingerprint Cards AB (publ) Fingerprint Cards AB (FPC) is a high tech and listed company which develops, produces and markets biometric technology that through the analysis and matching of an individual's unique fingerprint verify the person's identity. A secure and convenient user experience is thus made possible, beyond keys and pins. The FPC technology offers world class advantages and include unique image quality, extreme robustness, low power consumption and complete biometric systems. With these advantages and in combination with low production costs the technology may be implemented in large volume products as smartphones, tablets and biometric cards where these demands are extremely high. FPC's technology have user cases from a number of applications.

This is information that Fingerprint Cards AB is obliged to make public pursuant to the Swedish Securities Market Act and/or the Swedish Financial Trading Act. The information was submitted for publication, through the contact person set out above, on February 27, 2017 at 07:30 CET.   

Important information Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the constituent information in accordance with the rules and regulations prevailing in the particular jurisdiction. This press release does not constitute an offer, or invitation to acquire or subscribe for new securities in Fingerprint Cards in any jurisdiction.

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...996138c71c

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 188

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 384

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 260

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 267

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 392

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 382

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 371

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 472

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 344

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 433

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
/news?page=2">More News Articles